Published in Gut Pathog on February 27, 2011
Timely approaches to identify probiotic species of the genus Lactobacillus. Gut Pathog (2013) 0.95
The Shift of an Intestinal "Microbiome" to a "Pathobiome" Governs the Course and Outcome of Sepsis Following Surgical Injury. Shock (2016) 0.90
Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med (2016) 0.86
Gut failure in critical care: old school versus new school. Ann Gastroenterol (2015) 0.85
Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC). Mol Nutr Food Res (2013) 0.83
SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrol (2014) 0.81
A comparative study of teaching clinical guideline for prevention of ventilator-associated pneumonia in two ways: face-to-face and workshop training on the knowledge and practice of nurses in the intensive care unit. J Adv Med Educ Prof (2015) 0.75
The intestinal microbiome and surgical disease. Curr Probl Surg (2016) 0.75
Ventilator-associated pneumonia. Am J Respir Crit Care Med (2002) 9.63
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg (2002) 3.81
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med (2010) 2.15
Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology (2007) 1.63
Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg (2006) 1.42
Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit Care Med (2003) 1.30
A prospective randomised trial of probiotics in critically ill patients. Clin Nutr (2005) 1.25
Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery (2007) 1.16
Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2007) 1.15
Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med (2010) 1.11
Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr (2007) 1.07
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care (2008) 1.06
Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract. BMC Microbiol (2008) 1.03
Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med (2008) 1.00
Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol (2005) 0.98
Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med (2008) 0.96
Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. Am J Crit Care (2010) 0.95
Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol Scand (2008) 0.92
Probiotic use in the critically ill. Indian J Pediatr (2008) 0.85
Probiotic therapy - recruiting old friends to fight new foes. Gut Pathog (2010) 0.84
Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients. Clin Nutr (2004) 0.84
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology (2004) 4.24
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci (2013) 3.11
The Selaginella genome identifies genetic changes associated with the evolution of vascular plants. Science (2011) 3.10
Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis (2009) 2.82
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta (2010) 2.31
Identification of clinical and laboratory markers for predicting eosinophilic esophagitis in adults. Digestion (2011) 2.15
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09
Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. Eur J Gastroenterol Hepatol (2015) 2.00
Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98
Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost (2003) 1.97
Therapeutic ERCP with the double-balloon enteroscope in patients with Roux-en-Y anastomosis. Gastrointest Endosc (2008) 1.92
Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation (2003) 1.90
Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.62
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol (2006) 1.62
Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J (2004) 1.57
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol (2007) 1.54
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol (2010) 1.52
Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol (2010) 1.49
Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol (2004) 1.47
Gold catalysts: nanoporous gold foams. Angew Chem Int Ed Engl (2006) 1.46
[Diagnostic and therapeutic utility of double balloon endoscopy: experience with 225 procedures]. Acta Gastroenterol Latinoam (2007) 1.45
Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol (2005) 1.43
Procaine hydrochloride fails to relieve pain in patients with acute pancreatitis. Digestion (2004) 1.42
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. Eur J Gastroenterol Hepatol (2008) 1.42
Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure. Thromb Haemost (2013) 1.41
Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem (2005) 1.39
Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol (2014) 1.39
The submucosal cushion does not improve the histologic evaluation of adenomatous colon polyps resected by snare polypectomy. Clin Gastroenterol Hepatol (2011) 1.37
Endoscopic retrograde cholangiopancreatography using the single balloon enteroscope technique in patients with Roux-en-Y anastomosis. Digestion (2009) 1.35
Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis (2004) 1.33
ERCP with the double balloon enteroscope in patients with Roux-en-Y anastomosis. Surg Endosc (2008) 1.31
Development and homeostasis of "resident" myeloid cells: the case of the microglia. Glia (2012) 1.30
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology (2006) 1.28
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology (2006) 1.26
Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation (2005) 1.25
Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin (2006) 1.25
Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol (2004) 1.25
Identification of gastric cancer patients by serum protein profiling. J Proteome Res (2004) 1.23
Advanced colon polypectomy. Clin Gastroenterol Hepatol (2009) 1.22
Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol (2003) 1.22
Macro-role of microRNA in gastric cancer. Dig Dis (2012) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med (2012) 1.18
Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion (2013) 1.17
Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol (2002) 1.17
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J (2003) 1.16
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis. J Neurol (2007) 1.16
Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. Neoplasia (2005) 1.15
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. J Proteome Res (2006) 1.14
Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood (2003) 1.13
Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol (2002) 1.13
A group-specific PCR assay for the detection of Helicobacteraceae in human gut. Helicobacter (2002) 1.13
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol (2008) 1.11
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget (2011) 1.11
Drug treatment of functional dyspepsia. World J Gastroenterol (2006) 1.11
Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter (2008) 1.10
A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis. Clin Gastroenterol Hepatol (2007) 1.10
World Gastroenterology Organisation global guideline: Constipation--a global perspective. J Clin Gastroenterol (2011) 1.10
Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol (2003) 1.09
Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy. Dig Dis Sci (2008) 1.09
Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol (2013) 1.09
Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol (2012) 1.09
Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. Pathol Res Pract (2010) 1.08
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics (2005) 1.08
Helicobacter pylori and gastroduodenal ulcer disease. Dtsch Arztebl Int (2009) 1.07
A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin Chem Lab Med (2003) 1.07
Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter (2011) 1.07
Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol (2005) 1.06
Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis (2002) 1.05
Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis (2008) 1.05
Helicobacter and gastric malignancies. Helicobacter (2007) 1.05
AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thromb Haemost (2003) 1.04
Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Dig Dis (2011) 1.04
New strategies for Helicobacter pylori eradication. Curr Opin Pharmacol (2008) 1.03
Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med (2003) 1.03
Treatment of Helicobacter pylori. Curr Opin Gastroenterol (2011) 1.03
The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol (2008) 1.02
Pegylated interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. J Infect (2005) 1.02
Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol (2008) 1.01
Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. Neoplasia (2007) 1.01
Development of vaccines against Helicobacter pylori. Expert Rev Vaccines (2009) 1.01
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood (2003) 1.01
Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia (2008) 1.00
Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. Int J Oncol (2005) 1.00
Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes (2003) 0.99
Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromes. Dev Cell (2013) 0.99
APC promoter methylation and protein expression in hepatocellular carcinoma. J Cancer Res Clin Oncol (2007) 0.99
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol (2007) 0.99
Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol (2011) 0.98
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC. Liver Int (2014) 0.98
Influence of contrast-enhanced computed tomography on course and outcome in patients with acute pancreatitis. Pancreas (2002) 0.98
EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. Gastrointest Endosc (2002) 0.97
Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res (2004) 0.97
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World J Gastroenterol (2008) 0.97